Image
Image

Rethinking Evidence: Leveraging Real-World Data to

Accelerate Drug Development


On-Demand


OM1-Logo-Blue.jpg


OM1 is pioneering cutting-edge healthcare innovation through its insights-driven technology and data. It specializes in personalized medicine, evidence generation, and real-world evidence (RWE) research powered by next-generation AI platforms, deep longitudinal data, and globally recognized thought leadership. OM1 is led by a diverse group of scientists, engineers, researchers, and clinicians with over 30 years of experience in RWE.

Image
Overview of Webinar:

As drug development becomes more complex and personalized, traditional randomized controlled trials (RCTs) are no longer sufficient to answer every research question—particularly in rare diseases, and situations lacking head-to-head comparisons. Regulators, payers and other stakeholders are increasingly turning to real-world evidence (RWE) to address the gaps, but concerns around data quality, fit-for-purpose study design, and regulatory acceptance remain.

This webinar will explore the challenges of using real-world data (RWD) in observational studies, and show how life sciences teams are leveraging automation and AI to accelerate development timelines, reduce burden on sites and patients, and generate high-quality, regulatory-ready insights. Learn how these innovations are unlocking more efficient, scalable, and fit-for-purpose approaches to evidence generation.

Featured Topics:

  • Designing fit-for-purpose RWE studies for regulatory and clinical impact
  • Data collection models that reduce burden on sites and patients
  • Using AI and unstructured data to derive new endpoints
  • Real-world case examples of successful observational programs

Speakers:

  • Nancy Dreyer, MPH, PhD, FISPE
    Chief, Scientific Advisory Board, OM1
  • Eric Schrock
    Chief Technology Officer and Head of Evidence Generation Solutions, OM1
Image
Download the Recording!

Lorem ipsum dolor sit amet consectetur adipisicing elit. Odit vero harum distinctio autem?

Lorem ipsum dolor sit amet consectetur adipisicing elit. Quam laborum reprehenderit amet in rerum id eum harum qui quos. A est consequatur reprehenderit necessitatibus repudiandae quia harum dolorum praesentium temporibus?

Form Title


Speakers:

  • Saad Rahman, Chief Product Officer
    SciMax Global LLC

Who Should Attend?

  • Clinical development and clinical operations
  • Regulatory affairs and regulatory strategy
  • Real-world evidence (RWE) and health economics & outcomes research (HEOR)
  • Rare disease program leadership
  • Medical affairs and post-marketing strategy
  • Payers

Video Title Lorem ipsum dolor sit amet.

Copyright ©